Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2 - PubMed (original) (raw)
. 2007 Jul 6;282(27):19302-12.
doi: 10.1074/jbc.M700665200. Epub 2007 May 11.
Affiliations
- PMID: 17500068
- DOI: 10.1074/jbc.M700665200
Free article
Tumor necrosis factor alpha (TNFalpha) stimulates Map4k4 expression through TNFalpha receptor 1 signaling to c-Jun and activating transcription factor 2
Gregory J Tesz et al. J Biol Chem. 2007.
Free article
Abstract
Tumor necrosis factor alpha (TNFalpha) is a cytokine secreted by macrophages and adipocytes that contributes to the low grade inflammation and insulin resistance observed in obesity. TNFalpha signaling decreases peroxisome proliferator-activated receptor gamma and glucose transporter isoform 4 (GLUT4) expression in adipocytes, impairing insulin action, and this is mediated in part by the yeast Ste20 protein kinase ortholog Map4k4. Here we show that Map4k4 expression is selectively up-regulated by TNFalpha, whereas the expression of the protein kinases JNK1/2, ERK1/2, p38 stress-activated protein kinase, and mitogen-activated protein kinase kinases 4/7 shows little or no response. Furthermore, the cytokines interleukin 1beta (IL-1beta) and IL-6 as well as lipopolysaccharide fail to increase Map4k4 mRNA levels in cultured adipocytes under conditions where TNFalpha elicits a 3-fold effect. Using agonistic and antagonistic antibodies and small interfering RNA (siRNA) against TNFalpha receptor 1 (TNFR1) and TNFalpha receptor 2 (TNFR2), we show that TNFR1, but not TNFR2, mediates the increase in Map4k4 expression. TNFR1, but not TNFR2, also mediates a potent effect of TNFalpha on the phosphorylation of JNK1/2 and p38 stress-activated protein kinase and their downstream transcription factor substrates c-Jun and activating transcription factor 2 (ATF2). siRNA-based depletion of c-Jun and ATF2 attenuated TNFalpha action on Map4k4 mRNA expression. Consistent with this concept, the phosphorylation of ATF2 along with the expression and phosphorylation of c-Jun by TNFalpha signaling was more robust and prolonged compared with that of IL-1beta, which failed to modulate Map4k4. These data reveal that TNFalpha selectively stimulates the expression of a key component of its own signaling pathway, Map4k4, through a TNFR1-dependent mechanism that targets the transcription factors c-Jun and ATF2.
Similar articles
- MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-alpha-induced insulin resistance.
Bouzakri K, Zierath JR. Bouzakri K, et al. J Biol Chem. 2007 Mar 16;282(11):7783-9. doi: 10.1074/jbc.M608602200. Epub 2007 Jan 16. J Biol Chem. 2007. PMID: 17227768 - Effects of paeoniflorin on tumor necrosis factor-α-induced insulin resistance and changes of adipokines in 3T3-L1 adipocytes.
Kong P, Chi R, Zhang L, Wang N, Lu Y. Kong P, et al. Fitoterapia. 2013 Dec;91:44-50. doi: 10.1016/j.fitote.2013.08.010. Epub 2013 Aug 23. Fitoterapia. 2013. PMID: 23978582 - An RNA interference-based screen identifies MAP4K4/NIK as a negative regulator of PPARgamma, adipogenesis, and insulin-responsive hexose transport.
Tang X, Guilherme A, Chakladar A, Powelka AM, Konda S, Virbasius JV, Nicoloro SM, Straubhaar J, Czech MP. Tang X, et al. Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2087-92. doi: 10.1073/pnas.0507660103. Epub 2006 Feb 3. Proc Natl Acad Sci U S A. 2006. PMID: 16461467 Free PMC article. - TNFα and Immune Checkpoint Inhibition: Friend or Foe for Lung Cancer?
Benoot T, Piccioni E, De Ridder K, Goyvaerts C. Benoot T, et al. Int J Mol Sci. 2021 Aug 13;22(16):8691. doi: 10.3390/ijms22168691. Int J Mol Sci. 2021. PMID: 34445397 Free PMC article. Review. - TNF/TNFR: drug target for autoimmune diseases and immune-mediated inflammatory diseases.
Doss GP, Agoramoorthy G, Chakraborty C. Doss GP, et al. Front Biosci (Landmark Ed). 2014 Jun 1;19(7):1028-40. doi: 10.2741/4265. Front Biosci (Landmark Ed). 2014. PMID: 24896334 Review.
Cited by
- HGK promotes metastatic dissemination in prostate cancer.
Garcia-Garcia S, Rodrigo-Faus M, Fonseca N, Manzano S, Győrffy B, Ocaña A, Bragado P, Porras A, Gutierrez-Uzquiza A. Garcia-Garcia S, et al. Sci Rep. 2021 Jun 10;11(1):12287. doi: 10.1038/s41598-021-91292-2. Sci Rep. 2021. PMID: 34112843 Free PMC article. - Dynamic changes in the proximitome of neutral sphingomyelinase-2 (nSMase2) in TNFα stimulated Jurkat cells.
Schöl M, Schempp R, Hennig T, Wigger D, Schumacher F, Kleuser B, Stigloher C, van Ham M, Jänsch L, Schneider-Schaulies S, Dölken L, Avota E. Schöl M, et al. Front Immunol. 2024 Jul 9;15:1435701. doi: 10.3389/fimmu.2024.1435701. eCollection 2024. Front Immunol. 2024. PMID: 39044828 Free PMC article. - RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27.
Puri V, Virbasius JV, Guilherme A, Czech MP. Puri V, et al. Acta Physiol (Oxf). 2008 Jan;192(1):103-15. doi: 10.1111/j.1748-1716.2007.01786.x. Acta Physiol (Oxf). 2008. PMID: 18171433 Free PMC article. Review. - NOXA1-dependent NADPH oxidase regulates redox signaling and phenotype of vascular smooth muscle cell during atherogenesis.
Vendrov AE, Sumida A, Canugovi C, Lozhkin A, Hayami T, Madamanchi NR, Runge MS. Vendrov AE, et al. Redox Biol. 2019 Feb;21:101063. doi: 10.1016/j.redox.2018.11.021. Epub 2018 Nov 29. Redox Biol. 2019. PMID: 30576919 Free PMC article. - mRNA of the pro-apoptotic gene BBC3 serves as a molecular marker for TNF-α-induced islet damage in humans.
Omori K, Mitsuhashi M, Ishiyama K, Nair I, Rawson J, Todorov I, Kandeel F, Mullen Y. Omori K, et al. Diabetologia. 2011 Aug;54(8):2056-66. doi: 10.1007/s00125-011-2183-8. Epub 2011 May 13. Diabetologia. 2011. PMID: 21567299
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous